• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Device Problems Leak/Splash (1354); Device Dislodged or Dislocated (2923)
Patient Problems Aneurysm (1708); Hemorrhage/Bleeding (1888); Therapeutic Response, Decreased (2271)
Event Date 11/18/2015
Event Type  Injury  
Manufacturer Narrative
Literature citation: chaudhuri a, dey r, multi-component parallel endografts at complex tevar may be prone to modular dislocation causing novel endoleaks: a tale of two cases, ejves short reports (2015), http://dx.Doi.Org/10.1016/j.Ejvssr.2015.10.004.Concomitant medical products: alpha thoracic, cook aortic device, 8mm x 10cm gore viabahn endoprostheses with propaten bioactive surface no lot number information was supplied; therefore, no review of the manufacturing paperwork could be performed.The device remained implanted; consequently, a direct product analysis was not possible.(b)(4).
 
Event Description
In the medical literature, "multi-component parallel endografts at complex tevar may be prone to modular dislocation causing novel endoleaks: a tale of two cases" was reviewed.Two cases of complex thoracic endovascular aneurysm repair (tevar) with endoleakage due to modular dislocation of multi-component left subclavian parallel endografts in periscope configuration were reported.In this case, a (b)(6) female presented with a 75mm thoracic aortic aneurysm.She underwent a hybrid periscope-tevar procedure using two overlapped thoracic endoprostheses (alpha thoracic, cook aortic) and two 8mm x 10cm gore viabahn endoprostheses with propaten bioactive surface.The gore viabahn endoprostheses were synchronously deployed as a left subclavian artery periscope via an open brachial approach with an intentioned 2-cm overlap.After 48 hours, the patient was discharged with no complications and a palpable left radial pulse.It was stated that a computed tomography angiogram in the second week post procedure revealed modular dislocation between the two gore viabahn endoprostheses with endoleakage into the thoracic aortic aneurysm sac.A repeat computed tomography angiogram at 8 weeks post procedure revealed sac enlargement to 85mm with both components of the left subclavian artery periscope still patent.The patient underwent an urgent re-line of the left subclavian artery periscope.The two components of the periscope were bridged with an 8mm x 10cm gore viabahn endoprosthesis with propaten bioactive surface.The completion angiogram revealed no endoleaks and the patient was discharged home with a good left radial pulse, and no neurological complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN® ENDOPROSTHESIS
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86001
Manufacturer Contact
sandra whicker
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key5299954
MDR Text Key33597107
Report Number2017233-2015-00886
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,litera
Reporter Occupation Physician
Type of Report Initial
Report Date 11/19/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/15/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age67 YR
-
-